A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis.

This study has been completed.

Study NCT00203073 Information provided by Teva Pharmaceutical Industries

First Received: September 13, 2005 Last Updated: April 13, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2005
Primary Completion Date:	January 2005 (Final data collection date for primary outcome measure)